Dysosteosclerosis

Dysosteosclerosis (DSS) is an extremely rare, genetically heterogeneous sclerosing bone dysplasia classified within the osteopetrosis and related disorders group.[1][2] It is caused by defective osteoclast differentiation or function, resulting in impaired bone resorption with progressive skeletal sclerosis and modeling abnormalities.[2][3] The pathogenesis involves disruption of osteoclastogenesis through mutations in genes essential for osteoclast biology, including SLC29A3 (encoding the ENT3 nucleoside transporter), TNFRSF11A (encoding RANK), TCIRG1, LRRK1, and CSF1R.[1][3][4][5] The condition manifests in infancy or early childhood with fractures, short stature, cranial nerve palsies, and dental abnormalities.[2][6] Radiographically, DSS is distinguished from classic osteopetrosis by the combination of irregular metaphyseal osteosclerosis, platyspondyly, and paradoxical diaphyseal radiolucency with cortical thinning.[1][7] In the jaws, diffuse osteosclerosis with abnormal dentition and failure of tooth eruption are characteristic findings.[2][6] Management is primarily supportive, with hematopoietic stem cell transplantation considered in select genotypes.[8]

• Dysosteosclerosis (DSS or DOS) is the accepted term, first applied by Spranger et al. in 1968.[6][7]
• The condition is classified within the "increased bone density group" of the Nosology and Classification of Genetic Skeletal Disorders alongside osteopetrosis and related sclerosing dysplasias.[1][9]
• BANDDOS (Brain Abnormalities, Neurodegeneration, and Dysosteosclerosis; OMIM 618476) designates the specific phenotype caused by biallelic CSF1R mutations, which combines a DSS-like skeletal phenotype with progressive leukoencephalopathy and brain malformations.[10][11]
• The spelling variant "dysosteosclerosis" and the abbreviation "DOS" appear interchangeably in the literature; both refer to the same entity.[4]
• DSS should not be confused with dysostosis or dysosteogenesis, which denote different skeletal conditions.

DSS is exceedingly rare. Fewer than 30 cases had been reported in the literature through the early 2020s.[1][6] Key demographic patterns:

• Age of presentation: Infancy to early childhood; osteosclerosis may be detected as early as 7 months of age.[2]
• Sex: Published case series show a male predominance, which initially suggested X-linked recessive inheritance in some families. However, autosomal recessive inheritance is established for most molecularly confirmed cases.[1][2][3][6]
• Consanguinity: Reported in multiple families, consistent with autosomal recessive transmission.[2][6]
• Geographic and ethnic distribution: Cases have been reported across diverse populations including European, Turkish, Japanese, and Indian families, with no clear ethnic predilection.[4][5][12]

Presentation and Symptoms

DSS typically presents in infancy or early childhood. The principal presenting features include:

• Fractures: The most common initial manifestation; pathologic fractures occur after minimal trauma and may begin in infancy, particularly in SLC29A3-associated DSS.[1][2]
• Short stature: Progressive growth failure with length declining to below −2 SD.[2]
• Cranial nerve palsies: Cranial base sclerosis narrows neural foramina, leading to optic atrophy and blindness (frequently in infancy or early childhood), facial nerve paralysis, and sensorineural hearing loss. Notably, cranial nerve involvement is not observed in SLC29A3-associated DSS.[1][6]
• Developmental delay and neurologic deterioration: Present in the majority of reported cases; seizures and spasticity are common. Some apparent cognitive impairment may reflect sensory deprivation from blindness and deafness rather than primary neurodegeneration.[6]

Craniofacial and Dental Findings

• Dysmorphic facies: Round face, sagging cheeks, frontal bossing, and macrocephaly.[2][13]
• Dental abnormalities: Failure of tooth eruption, delayed eruption of deciduous teeth, oligodontia, and abnormal tooth morphology are major clinical findings. One adult patient reported primary teeth erupting throughout his twenties.[2][6]
• Osteomyelitis of the jaws: Reported as a complication, analogous to the well-recognized susceptibility in osteopetrosis, where sclerotic, poorly vascularized bone predisposes to infection following dental procedures or odontogenic infection.[6][14]

Other Findings

• Blue sclerae have been noted.[2]
• Skin findings: Red-violet macular atrophy is described in SLC29A3-associated DSS, distinguishing it from other genetic subtypes.[3]
• Hepatosplenomegaly may occur.[7]
• Genu valgum and progressive limb bowing.[2][13]

Tempo and Prognosis

The clinical course is progressive. Death in infancy or childhood has been reported in several cases.[6] However, survival to adulthood is documented; one patient was followed to age 46 years.[6]

Location and Distribution

DSS produces a generalized skeletal sclerosis with characteristic regional variation. In the craniofacial skeleton:

• Skull base: Sclerosis predominantly affects the cranial base, with relative sparing of the calvarium in early disease — a key distinction from classic osteopetrosis, which shows significant vault involvement.[7]
• Facial bones and jaws: Diffuse sclerosis of the maxilla and mandible is characteristic. Cranial tomography in one adult patient demonstrated diffuse sclerosis of the mandible, maxilla, mastoid, skull, and skull base.[6]
• Paranasal sinuses: Hypoplasia of the sinuses has been reported.[6]

The appendicular and axial skeleton are also affected, with dense ribs, sclerotic scapulae and clavicles, and involvement of the pelvis showing a bone-in-bone appearance.[2][12][13]

Internal Architecture

The hallmark internal pattern of DSS is alternating bands of sclerotic and normal-density bone within the metaphyses and spine, producing a distinctive heterogeneous appearance:[7][13]

• Long bones: Meta-diaphyseal regions show irregular, patchy osteosclerosis with interspersed areas of relative radiolucency, contrasting with the homogeneous sclerosis of classic osteopetrosis.[7]
• Vertebral bodies: Sclerotic endplates with relative central radiolucency produce a sandwich appearance (analogous to the "Rugger Jersey" spine of renal osteodystrophy). Platyspondyly is a consistent finding, with vertebral bodies becoming progressively flattened, small, and anteriorly beaked.[2][5][12][13]
• Jaws: The mandible and maxilla show diffuse increased radiodensity with loss of normal trabecular architecture. Abnormal-appearing unerupted teeth may be visible within sclerotic alveolar bone.[6]

Periphery and Shape

• Metaphyseal widening: Progressive bulbous expansion of the metaphyses is characteristic, producing an Erlenmeyer flask deformity (EFD). This EFD is classified as "atypical" (EFD-A), with radiographically dense, abnormal-appearing bone rather than the translucent expanded metaphyses seen in Pyle disease.[7]
• Cortical thinning: Despite metaphyseal sclerosis, the cortices of long bone diaphyses become paradoxically thin with advancing age.[1][2][6]

Effects on Teeth and Adjacent Structures

• Failure of tooth eruption: Sclerotic alveolar bone impedes normal eruption of both deciduous and permanent teeth.[2][6]
• Oligodontia and dental malformation: Multiple missing teeth and morphologically abnormal teeth are reported.[6]
• Neural foramina narrowing: Skull base sclerosis narrows the optic canals, internal auditory canals, and other cranial nerve foramina, producing compressive neuropathies.[6]
• Spinal canal stenosis: Marked central canal stenosis at C1–C2 has been documented.[6]

Evolving Radiographic Phenotype

A distinctive feature of DSS is the temporal evolution of the radiographic appearance:[1][12]

• In infancy and early childhood, diffuse osteosclerosis predominates, closely resembling osteopetrosis.
• With increasing age, metaphyseal and appendicular osteosclerosis variably fades, likely due to residual osteoclast function, and is replaced by osteopenia with thin cortical bone.[1][2][6]
• Platyspondyly progresses, with vertebral bodies changing from ovoid to flattened and anteriorly beaked.[2]
• In adulthood, the primary radiographic feature may be osteopenia with less pronounced sclerotic changes.[6]

Variants by Genotype

Radiographic severity and distribution vary by underlying gene defect:[1][5][12]

• SLC29A3-associated DSS: Ranges from narrow metaphyseal sclerotic bands to diffuse osteosclerosis extending into the diaphysis; cranial base sclerosis is mild.[12]
• TNFRSF11A-associated DSS: Irregular osteosclerosis with platyspondyly; overlaps phenotypically with osteoclast-poor osteopetrosis.[4][15]
• TCIRG1-associated DSS: May present with extreme metaphyseal flaring and uniform osteosclerosis.[5]
• CSF1R-associated DSS (BANDDOS): Skeletal phenotype spans a DOS–Pyle disease spectrum with variable osteosclerosis and metaphyseal widening.[11][16]

CT of the Skull Base and Spine

Medical CT provides critical detail for evaluating complications of cranial base sclerosis. In one comprehensively studied adult, CT demonstrated:

• Diffuse sclerosis of the mandible, maxilla, mastoid, skull, and skull base with marked narrowing of neural foramina.[6]
• Central canal stenosis at C1–C2.[6]
• Hypoplastic paranasal sinuses.[6]

CT is the modality of choice for assessing foraminal narrowing that threatens cranial nerves, particularly the optic canals and internal auditory canals, and for surgical planning of decompression procedures.[1][6][17]

MRI of the Brain

In CSF1R-associated DSS (BANDDOS), brain MRI reveals characteristic abnormalities including progressive white matter changes, agenesis of the corpus callosum, ventriculomegaly, Dandy-Walker complex, cortical abnormalities, and intracranial calcifications.[10][11][18] These findings are not typical of other DSS genotypes and help distinguish BANDDOS from other forms of DSS.

Intracranial extramedullary hematopoiesis has been reported in TNFRSF11A-associated DSS as an extremely rare finding.[19]

The differential diagnosis of DSS centers on distinguishing it from other sclerosing bone dysplasias that produce generalized osteosclerosis, craniofacial involvement, and dental abnormalities. The combination of irregular metaphyseal osteosclerosis with alternating bands of sclerotic and normal bone, platyspondyly, and paradoxical diaphyseal osteopenia is the key discriminating pattern.[1][7]

The highest-risk diagnostic pitfall is misclassification of DSS as infantile malignant osteopetrosis, because the two conditions share early osteosclerosis, cranial nerve compression, and tooth eruption failure. Distinguishing them is critical: osteopetrosis may be curable with hematopoietic stem cell transplantation, whereas the indication for HSCT in DSS depends on the specific genotype.[1][8] Genetic testing (next-generation sequencing panels for sclerosing bone dysplasias) is essential for definitive diagnosis and guides treatment decisions.[1][5]

Bone Histology

The defining histopathologic finding in DSS during childhood is an osteoclast-poor pattern with excessive unresorbed primary spongiosa:[2][3]

• Iliac crest biopsy in a 3-year-old patient showed abundant primary spongiosa filling the marrow space with a complete absence of osteoclasts.[2]
• Serum bone turnover markers (bone alkaline phosphatase, osteocalcin, TRACP-5b) are characteristically subnormal, consistent with deficient osteoclast activity.[2]

Osteoclast Differentiation Defect

In vitro studies of monocytes from patients with SLC29A3-associated DSS demonstrate reduced osteoclast differentiation and impaired demineralization function.[3] The SLC29A3-encoded ENT3 nucleoside transporter is expressed in osteoclasts and is essential for lysosomal function; its disruption impairs osteoclastogenesis through a mechanism distinct from classic osteopetrosis genes.[3][12]

Radiologic-Pathologic Correlation

The paradoxical evolution from childhood osteosclerosis to adolescent/adult osteopenia remains incompletely understood. It is hypothesized that residual osteoclast function gradually resorbs the sclerotic bone but is insufficient to maintain normal remodeling, resulting in thin cortices and fragile bone.[1][2] This evolving histologic picture explains the age-dependent radiographic phenotype.

Neuropathology (BANDDOS)

In CSF1R-associated DSS, brain autopsy has demonstrated absence of microglia, severe white matter atrophy with axonal spheroids, gliosis, and dystrophic calcifications — findings that overlap with CSF1R-related adult-onset leukoencephalopathy (ALSP).[10]

Workup and Referral

• Genetic testing is the cornerstone of diagnosis. Next-generation sequencing panels covering SLC29A3, TNFRSF11A, TCIRG1, LRRK1, CSF1R, and other osteopetrosis-related genes should be pursued in any child with a sclerosing bone dysplasia phenotype.[1][5]
• Ophthalmologic and audiologic evaluation should be performed early and serially to detect cranial nerve compression.[1][6]
• CT of the skull base is indicated to assess foraminal narrowing when cranial nerve deficits are present or suspected.[6][17]
• Dental evaluation should be initiated early given the high frequency of eruption failure, oligodontia, and susceptibility to osteomyelitis.[6]

Treatment

No curative therapy exists for most forms of DSS. Management is largely supportive:

• Fracture prevention and management: Calcium and vitamin D supplementation; activity modification to reduce fracture risk.[2][6]
• Hematopoietic stem cell transplantation (HSCT): HSCT is the treatment of choice for osteoclast-intrinsic forms of osteopetrosis (e.g., TNFRSF11A/RANK-deficient disease) and may be considered in DSS caused by genes affecting osteoclast differentiation from hematopoietic precursors. However, HSCT is contraindicated in RANKL-deficient disease and in forms with primary neurodegeneration.[8][23]
• Surgical decompression of cranial nerve foramina may be required for progressive optic nerve or facial nerve compression.[6]
• Dental management requires awareness of the high risk of osteomyelitis in sclerotic jaws; prophylactic antibiotics and conservative approaches to extractions are advisable, paralleling protocols for osteopetrosis.[6][14][24]

Prognosis

• The long-term prognosis is generally considered poor, with death in infancy or childhood reported in several cases.[6]
• Survival to adulthood is possible, as demonstrated by a patient followed to age 46 years, though with significant morbidity including blindness, deafness, recurrent fractures, and osteomyelitis.[6]
• CSF1R-associated DSS (BANDDOS) carries a particularly severe neurologic prognosis with progressive leukoencephalopathy.[10][11]
• Gene-specific complications and prognosis underscore the importance of molecular diagnosis for appropriate health surveillance and family counseling.[1]

Genotype-Phenotype Associations

The genetic heterogeneity of DSS has important implications for clinical management:[1]

• SLC29A3 mutations: Associated with skin findings (red-violet macular atrophy, hyperpigmentation) that overlap with histiocytosis-lymphadenopathy plus syndrome; cranial nerve involvement is typically absent; osteosclerosis may resolve with age.[1][3][12]
• TNFRSF11A mutations: Phenotypic overlap with osteoclast-poor osteopetrosis (OP-AR7); hypogammaglobulinemia may occur; HSCT may be beneficial.[4][23]
• CSF1R mutations (BANDDOS): The neurologic component — progressive leukoencephalopathy, brain malformations, seizures — dominates the clinical picture and may be the primary cause of morbidity and mortality; skeletal findings may be variable.[10][11][18]
• TCIRG1 mutations: Expand the molecular heterogeneity, as intermediate autosomal recessive osteopetrosis due to TCIRG1 splice-site mutations can present with a DSS-like phenotype including platyspondyly.[5]

Pediatric Considerations

DSS is almost exclusively a pediatric diagnosis. Early genetic testing enables appropriate surveillance for genotype-specific complications, timely referral for HSCT evaluation